Literature DB >> 24138291

Factors influencing long-term outcome after kidney transplantation.

Christophe Legendre1, Guillaume Canaud, Frank Martinez.   

Abstract

Many factors influence the long-term outcome of kidney transplantation, which is defined very schematically by patient death or renal dysfunction leading to graft loss. The most important of these factors is most likely the quality of the transplant itself, with kidneys from living donors showing a positive impact, while kidneys from expanded criteria donors show deleterious impacts. Various clinicopathological scores exist to predict mid- to long-term outcomes and avoid the transplantation of kidneys displaying inferior results. The key factors related to the recipient include their age as well as disease recurrence, HLA matching, HLA immunization, ethnic background, time on dialysis, and cardiovascular comorbidities. Renal function, defined based on estimated GFR and/or proteinuria values, is a result of all these factors. Delayed graft function has a detrimental long-term impact, as does the level of renal function impairment either in stable condition or in case of progressing dysfunction. Finally, although current immunosuppression regimes are highly efficient in preventing acute rejection, the burden of specific (diabetes, nephrotoxicity) and nonspecific (infection and cancer) side effects has significant negative long-term consequences that may well be worse in the future because of the increasing ages of both donors and recipients. The development of safer immunosuppression strategies is therefore crucial to improve long-term outcomes.
© 2013 Steunstichting ESOT. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  antibody-mediated rejection; cardiovascular mortality; delayed graft function; donor-specific antibodies; graft function; kidney donor

Mesh:

Substances:

Year:  2013        PMID: 24138291     DOI: 10.1111/tri.12217

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  63 in total

1.  Single nucleotide variant counts computed from RNA sequencing and cellular traffic into human kidney allografts.

Authors:  Gaurav Thareja; Hua Yang; Shahina Hayat; Franco B Mueller; John R Lee; Michelle Lubetzky; Darshana M Dadhania; Aziz Belkadi; Surya V Seshan; Karsten Suhre; Manikkam Suthanthiran; Thangamani Muthukumar
Journal:  Am J Transplant       Date:  2018-05-15       Impact factor: 8.086

2.  Osmoregulation Performance and Kidney Transplant Outcome.

Authors:  Manal Mazloum; Jordan Jouffroy; François Brazier; Christophe Legendre; Antoine Neuraz; Nicolas Garcelon; Dominique Prié; Dany Anglicheau; Frank Bienaimé
Journal:  J Am Soc Nephrol       Date:  2019-06-19       Impact factor: 10.121

3.  Landscape of innate immune system transcriptome and acute T cell-mediated rejection of human kidney allografts.

Authors:  Franco B Mueller; Hua Yang; Michelle Lubetzky; Akanksha Verma; John R Lee; Darshana M Dadhania; Jenny Z Xiang; Steven P Salvatore; Surya V Seshan; Vijay K Sharma; Olivier Elemento; Manikkam Suthanthiran; Thangamani Muthukumar
Journal:  JCI Insight       Date:  2019-07-11

4.  Targeted delivery of immune therapeutics to lymph nodes prolongs cardiac allograft survival.

Authors:  Baharak Bahmani; Mayuko Uehara; Liwei Jiang; Farideh Ordikhani; Naima Banouni; Takaharu Ichimura; Zhabiz Solhjou; Georg J Furtmüller; Gerald Brandacher; David Alvarez; Ulrich H von Andrian; Kenji Uchimura; Qiaobing Xu; Ishaan Vohra; Osman A Yilmam; Yousef Haik; Jamil Azzi; Vivek Kasinath; Jonathan S Bromberg; Martina M McGrath; Reza Abdi
Journal:  J Clin Invest       Date:  2018-10-02       Impact factor: 14.808

5.  Restoration of renal function does not correct impairment of uremic HDL properties.

Authors:  Chantal Kopecky; Michael Haidinger; Ruth Birner-Grünberger; Barbara Darnhofer; Christopher C Kaltenecker; Gunther Marsche; Michael Holzer; Thomas Weichhart; Marlies Antlanger; Johannes J Kovarik; Johannes Werzowa; Manfred Hecking; Marcus D Säemann
Journal:  J Am Soc Nephrol       Date:  2014-07-28       Impact factor: 10.121

6.  Epidermal Desmoglein 1 Expression Is Reduced in Kidney Transplant Recipients Compared with Immunocompetent Patients.

Authors:  Jodi L Johnson; Paul Hoover; Borko D Jovanovic; Kathleen J Green; John J Friedewald; June K Robinson
Journal:  J Invest Dermatol       Date:  2016-06-11       Impact factor: 8.551

7.  Use of computed tomography assessed kidney length to predict split renal GFR in living kidney donors.

Authors:  François Gaillard; Patrik Pavlov; Anne-Marie Tissier; Benoit Harache; Dominique Eladari; Marc-Olivier Timsit; Catherine Fournier; Carine Léon; Chantal Hignette; Gérard Friedlander; Jean-Michel Correas; Pierre Weinmann; Arnaud Méjean; Pascal Houillier; Christophe Legendre; Marie Courbebaisse
Journal:  Eur Radiol       Date:  2016-05-24       Impact factor: 5.315

8.  Relationship of Transforming Growth Factor-βl and Arginase-1 Levels with Long-term Survival after Kidney Transplantation.

Authors:  Xiao-Xiao Du; Yu-Liang Guo; Min Yang; Yan Yu; Sheng Chang; Bin Liu; Lan-Jun Cai; Zhong-Hua Klaus Chen
Journal:  Curr Med Sci       Date:  2018-06-22

9.  Blood dendritic cell levels associated with impaired IL-12 production and T-cell deficiency in patients with kidney disease: implications for post-transplant viral infections.

Authors:  Ping Chen; Qianmei Sun; Yanfei Huang; Mohamed G Atta; Sharon Turban; Dorry L Segev; Kieren A Marr; Fizza F Naqvi; Nada Alachkar; Edward S Kraus; Karl L Womer
Journal:  Transpl Int       Date:  2014-08-20       Impact factor: 3.782

10.  Association of mGFR of the Remaining Kidney Divided by Its Volume before Donation with Functional Gain in mGFR among Living Kidney Donors.

Authors:  Marie Courbebaisse; François Gaillard; Anne-Marie Tissier; Catherine Fournier; Alexis Le Nestour; Jean-Michel Corréas; Hind Slimani-Thevenet; Frank Martinez; Carine Léon; Dominique Eladari; Marc-Olivier Timsit; Philippe Otal; Chantal Hignette; Gérard Friedlander; Arnaud Méjean; Pascal Houillier; Nassim Kamar; Christophe Legendre
Journal:  Clin J Am Soc Nephrol       Date:  2016-05-17       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.